- Zulresso is the first FDA approved medication to treat postpartum depression.
- This 60 hour IV infusion is delivered at Barnes Jewish Hospital.
- Zulresso may be the right choice for you if you are experiencing moderate to severe depression and had a baby within the past year.
For more information regarding Zulresso treatment call Molly Mendoza at 314-747-8356
What can I expect from Zulresso (Brexanolone)?
Zulresso is given to you in the hospital through a continuous intravenous (IV) infusion over 3 days At Barnes-Jewish Hospital. This takes place in the antepartum unit (an OB floor) in comfortable rooms with space for your family to visit. If you have another adult with you, your baby can also stay in this room during the day.
What is Zulresso (Brexanolone)?
Zulresso is the first FDA-approved drug to treat postpartum depression (PPD).
In clinical studies, new parents treated with Zulresso experienced a greater reduction in symptoms of PPD vs placebo in 2.5 days. Symptoms were measured at the beginning of treatment using a standard depression scale and again at the end of treatment. In these studies, new parents who took Zulresso generally still felt better 30 days after treatment began.
When you call us to ask about Zulresso (Brexanolone), A staff member will ask you questions over the phone about your mental health and medical history. You may then meet with a psychiatrist or psychologist at Washington University Medical School, usually the following week. If Brexanolone (Zulresso) is the right treatment for you, we will help you get scheduled at Barnes Jewish Hospital. Zulresso is covered by most insurance companies. Call 314-747-8356 for more information.